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Cooperation  between  thymus-derived  (T) a lymphocytes and  non-thymus-derived 
(B) lymphocytes has been shown to be necessary for the antibody response to protein 
antigens in experimental animals (1) and in man (2). Supernates of antigen-stimulated 
T  cells can replace T  cells for the in vitro antibody response by B cells (3). Two classes 
of T-ceU helper factors have been demonstrated in experimental animals: nonspecific 
helper  factors and  antigen  specific helper  factors.  Nonspecific T-cell  helper  factors 
(NSF)  behave  like  polyclonal  B-cell  activators.  They  trigger autologous  as  well  as 
allogeneic B cells to proliferate and secrete antibodies against  a  variety of antigens 
(4). On the other hand, antigen-specific helper factors (ASF) induce B cells to produce 
antibody that is directed exclusively against the antigen used to elicit the T-cell helper 
activity  (5).  In mice, ASF can be absorbed on  immunosorbent  columns containing 
the antigen used to raise the factor as well as on immunosorbent columns containing 
antisera to Ia determinants expressed on the cells that produced the factor (6).  It has 
been thus suggested that ASF contains an antigen-binding site as well as determinants 
encoded for by the Ia region of the major histocompatibility complex. 
Previous work in our laboratory has demonstrated that supernates of tetanus toxoid 
(TT)-stimulated human T cells contain a helper factor, termed lymphocyte mitogenic 
factor  (LMF-TT)  which  induces  proliferation,  IgG synthesis,  and  specific anti-TT 
antibody  synthesis  in  autologous  as  well  as  allogeneic  B  cells  (2).  Further  work 
identified the presence of NSF in these supernates  (7).  It was shown that supernates 
depleted of TT antigen by passage over anti-TT immunosorbent columns were still 
capable of inducing proliferation and IgG synthesis in as much as 35-50% of B cells. 
Furthermore,  NSF  could  induce  specific antibody  synthesis  against  TT  as  well  as 
against  an unrelated  antigen  such  as diphtheria  toxoid  (DT)  provided that  second 
antigen was added to the T-cell cultures and provided the B-cell donor was immune 
to that antigen. The purpose of the present study was to identify ASF activity in the 
supernates of TT-stimulated human T  lymphocytes. 
Materials and Methods 
Antigens,  Antzbodies and Enzymes.  DT and TT were obtained from Massachusetts Biological 
Laboratories, Boston,  Mass.  They were purified by Sephadex G-200 chromatography (Phar- 
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macia Fine Chemicals, Div. of Pharmacia Inc., Piscataway,  N. J.).  More  than 90%  of the 
material that eluted in the second protein peak was precipitable by specific rabbit antiserum. 
Iodination of TT and DT was carried with carrier-free iodine ~25I by the chloramine-T method 
(8). 
Anti-TT and  anti-DT antisera  were  raised  in  rabbits  immunized with  the  antigen in 
complete ~'reund's adjuvant. Antibody titers to DT and "l'q" were determined by hemaggluti- 
nation of sheep erythroeytes coated with antigen using chromic chloride (9). They ranged from 
1/8,000 to (and)  1/32,000.  Rabbit anti-human IgG and anti-human IgM antisera specific  to 
the heavy chain determinants were  obtained from  Behring Diagnostics, American Hoechst 
Corp., Somerville, N. J. 
Specific  antisera  for  B-lymphocyte antigens  (anti-DRW antisera)  defined  in  the  VIhh 
International Histocompatibility Workshop were used. Typing was performed using the stan- 
dard methodology of that workshop (10). 
Insolubilized ficin, amylase, and RNAase were  purchased from Sigma Chemical Co., St. 
Louis, Mo.  Insolubilized trypsin was obtained from Miles Laboratories Inc., Miles Research 
Products, Elkhart, Ind. and insolubilized  DNAase was obtained from Worthington Biochemical 
Corp., Freehold, N. J. 
Anti-ldiotypic Antisera.  Rabbit anti-idiotypic antiserum to anti-TT antibodies was raised in 
rabbits as described elsewhere9 Briefly,  IgG from 1,000 ml of human plasma was purified by 
precipitation in 50%  (NH4)~SO4 followed  by DEAE cellulose column chromatography. The 
purified IgG was digested with pepsin for 36 h at 37°C in a 0.1-M acetate buffer, pH 4.5. F 
(ab)2 fragments were separated over a column of Sephadex G  150 (Pharmacia Fine Chemicals, 
Div. of Pharmacia Inc.) then circulated over a TT-immunosorbent  column. The material that 
bound to the column, F  (al~).~ anti-'l~F, was used to raise idiotypic antiserum in rabbits. The 
IgG fraction of the rabbit antiserum was  rendered idiotype specific  by extensive absorption 
against  homologous TT  nonreactive F  (al~)~. Anti-idiotypic antisera were  shown  to  bind 
specifically to the immunizing  F (al~)2 anti-TT. High concentrations of antiserum bound >85% 
12~  of  '~I-radiolabeled  F  (al~)2 anti-TT but  failed completely to  bind to  r'SI-radiolabeled "vr 
nonreactive F (al~)2. Studies with anti-idiotypic  antisera have revealed minimal cross-reactivity, 
if any, between the idiotypic determinants of unrelated individuals because these antisera, even 
when used  in high concentration, bound minimal amounts (<10%)  of radiolabeled F  (al~)2 
anti-TT derived from unrelated individuals. Furthermore, anti-idiotypic antisera were shown 
to inhibit the binding of t2~I-radiolabeled  TT antigen to IgG derived from the donor of the 
immunizing F (ab)2 anti-TT but inhibited poorly or not at all the binding of TT to IgG from 
unrelated donors. Anti-idiotypic antisera exhibited great specificity  for the species of antibody 
molecules against which they were directed. Thus, anti-idiotypic antisera failed completely to 
inhibit the  binding of J2~I-radiolabeled  DT antigen to  IgG derived  from  the  donor of the 
immunizing F (ab)z anti-TT. 
Immunosorbents.  The IgG fraction was  purified from serum by diethylaminoethylcellulose 
(DEAE 32, Whatman Chemicals, Maidstone, Kent, England) chromatography using a 0.01-M 
pH 6.8 phosphate buffer as eluting buffer. Proteins were dialyzed against 0.1 M NaHCO3 and 
cross-linked  to  Sepharose  4B  beads  (Pharmacia  Fine Chemicals,  Div.  of  Pharmacia  Inc.) 
activated by the cyanogen bromide method of Axen and Ernback (11). The effiiziency of protein 
coupling to Sepharose beads exceeded  80% in all instances. 
Preparation of Lympho(ytes.  Peripheral  mononuclear cells  were  isolated  from  heparinized 
blood on Ficoll-Hypaque gradients (Pharmacia Fine Chemicals, Div. of Pharmacia Inc.) (t2) 
or by means of a cell separator (Haemonetics, model  10, Haemonetics Corp., Natick, Mass.). 
90% of the cells were mononuclear and viability exceeded 90% as determined by trypan blue 
exclusion.  Cells  were  washed  three  times  before  use  with  Hank's  balanced  salt  solution 
(Microbiological Associates, Walkersville, Md.)  (HBSS). 
Preparation of T-Cell-Rich Lymphocyte Suspensions.  Lymphocyte populations rich in T cells were 
purified over nylon wool columns as described by Julius et al. (13). 10-ml plastic syringes were 
densely packed with 600 mg of extensively washed nylon wool (LP-I Leukopak filter,  Fenwal, 
Inc., Walter Kidde & Co.  Inc., Ashland, Mass.)  and sterilized by autoclaving. Before use, the 
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column was washed with HBSS containing 5% fetal calf serum (FCS). 50 million mononuclear 
cells in 2 ml of HBSS-FCS were applied to the column drop by drop. After a 45-min incubation 
period at 37°C, the nonadherent cells were washed out of the column with 50 ml of HBSS-FCS 
medium  prewarmed  to 37°C.  95-98%  of the cells in the resulting suspension  formed rosettes 
with sheep erythrocytes. 
Preparation of  TMacrophage-Rich Populations.  Mononuclear cells were suspended at a concentra- 
tion of 1 X  10/ml in medium RPMI-1640 containing 10% FCS.  10 ml of cell suspension were 
incubated  at  37°C for  1 h  in a  Falcon plastic tissue culture  dish  (BioQuest,  BBL,  & Falcon 
Products,  Becton,  Dickinson,  &  Co.,  Cockeysville,  Md.).  At  the  end  of the  incubation  the 
nonadherent  cells were sucked off and the cells adherent  to the plates were washed three times 
with  10 ml of RPMI-1640 medium. The cells attached  to the dish were then overlayered with 
calcium-free phosphate-buffered saline (PBS) and incubated for 30 min at 4°C. The bottom of 
the dish was then gently scraped with a sterile rubber policeman, the contents of the dish were 
spun  at  200  g,  and  the  cell bu'tton  was  resuspended  in  culture  medium.  The  purity  of the 
adherent  cells as assessed by ingestion of 1.1 #m latex particles exceeded 93~. 
Preparation of B-Cell-Rich Lymphocyte Suspensions.  Lymphocyte suspensions rich in B cells were 
obtained by rosetting peripheral lymphocyte suspensions with sheep erythrocytes (E) pretreated 
with 50 U/ml neuraminidase  (14)  (Behring Diagnostics, American Hoechst Corp.)  for 30 min 
at 37°C and sedimenting the lymphocyte erythrocyte mixture over a  Ficoll-Hypaque gradient. 
The  E  non-rosette-forming  cells  which  floated  on  top  of the  gradient  were  rerosetted  and 
separated  on  another  Ficoll-Hypaque gradient,  and  the  final  floating cells were  used.  They 
contained <2%  E  rosette-forming cells and  70-80% surface immunofluorescence positive cells 
when stained with a fluorescein conjugated polyvalent anti-human immunoglobulin antiserum. 
Cell Cultures.  Lymphocytes  were  cultured  in  medium  199  or  RPMI-1640  (Grand  Island 
Biological Co., Grand  Island,  N.  Y.)  supplemented  with  15%  heat-inactivated  human  serum 
obtained  from donors with  type AB, Rh + erythrocytes, 50 U/ml penicillin G, and  50/.tg/ml 
streptomycin,  (complete medium).  They were then  placed in a  humidified incubator at  37°C 
in an atmosphere of 5% CO2 in air. 
Production of T-CYU Supernates.  Peripheral  blood  lymphocytes  or  alternatively  T-cell-rich 
lymphocytes containing 5% macrophages were cultured at a concentration of 1 ×  10  7 cells/ml 
in complete medium  199  for 48 h  with antigen  (TT 2-10/Lg/ml). A  duplicate set of cultures 
received an equivalent amount  of antigen at  the end of the incubation  period and  served as 
control. The incubation was terminated  by pelleting the cells at 200 g for  I0 min. Supernates 
were collected, filtered through a  0.45/.tm  filter (Millipore Corp., Bedford, Mass.), and stored 
at -20°C  until tested. 
Fractionation of T-CeU Supernates on TT-Immunosorbent Columns.  20 ml of T-cell supernates were 
circulated over immunosorbent columns of Sepharose 4B cross-linked to TT at a rate of 2 ml/ 
h  for 48 h at 4°C. The material that eluted spontaneously from the column was collected and 
designated  NSF.  This  material  was  previously shown  to  induce  proliferation,  IgG synthesis, 
and anti-'IT-antibody synthesis in both allogeneic and autologous B cells (7). The immunosor- 
bent column was then washed extensively with PBS, pH  7.2 for 24 h. The material  bound  to 
the column was then eluted with 3 M  NaCNS in a  volume equivalent to the original volume 
of supernates applied to the column, was dialyzed extensively and successively against 0.15  M 
NaCI  and  medium  RPMI-1640,  filtered  through  a  0.45-p,m  filter,  and  stored  in  1% human 
serum albumin  at  -20°C  until tested. This material was designated ASF. Experiments made 
with the addition  of 12'~I-TT to LMF-TT before passage over the column  demonstrated  that 
<5%  of the  radioactivity  was  retained  on  the  column.  Control  material  was  generated  by 
fractionating the T-cell supernates over an immunosorbent column consisting of Sepharose 4B 
cross-linked to DT. 
Fractionation of T-Cell  Supernates on  Anti-TT-Immunosorbent  Columns.  T-cell  supernates  were 
passed over an anti-TT immunosorbent  column as described above. The material that  eluted 
spontaneously  from the column was depleted of antigen and was shown previously to induce 
proliferation and  IgG synthesis in autologous, as well as allogeneic, T  ceils (7).  The material 
that bound to the column, which included the TT antigen present in the T-cell supernates, was 
eluted  with  3  M  NaCNS  and  processed  as  described  above.  Experiments  made  with  the 
addition  of ]25I-TT  to T-cell supernates  before their passage  over the column  demonstrated 
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NaCNS washings from the column revealed no detectable anti-TT activity as determined by 
a radioimmunoassay utilizing 125I-TT, with normal rabbit serum and goat anti-rabbit IgG at 
equivalence. Control material was  generated  by passing T-cell supernates over an anti-DT 
immunosorbent column. 
B-Cell Proliferation.  B lymphocytes were cultured in 0.2 ml cultures in the wells of mierotiter 
plates (BioQuest, BBL, & Falcon Products, Becton, Dickinson, & Co.)  at a concentration of 1 
×  106 cells/ml and in the presence of 50% unfractionated or fractionated T-cell supernates. 
After a 6-day incubation period, the cultures were pulsed with [3H]thymidine (New England 
Nuclear, Boston, Mass.,  sp act 2 Ci/mol) (0.5 p.Ci/culture) and harvested  16 h  later with an 
automatic tissue culture harvester (Skatron, Flow Laboratories, Inc., Rockville, Md.). Results 
were expressed  as counts per minute of [:~H]thymidine incorporated into DNA per culture and 
as mitotic index (MI) where: 
MI  =  cpm of ('3H)thymidine incorporated in stimulated culture 
cpm of ('~H)thymidkne incorporated in nonstimulated culture" 
lmmunoglobulin Synthesis.  B lymphocytes were cultured at 2  ×  106 cells/ml in sterile culture 
tubes (BioQuest, BBL, & Falcon Products, Becton, Dickinson, & Co.) in the presence of 50% T- 
cell supernates. Every 36 h, one-half  of the culture medium was removed and replaced with an 
equivalent amount of fresh culture medium. After 5 days of incubation, the cells were washed 
three times with HBSS and then resuspended at 4 ×  106 cells/ml in fresh RPMI-1640 medium 
deficient in L-valine, L-leucine, and L-isoleucine, and supplemented with 2 ~Ci/ml 14C-radio- 
active amino acids and with dialyzed fetal calf serum (Microbiological Associates, Walkersville, 
Md.). 48 h later, the B-cell culture fluid supernates were harvested, filtered through a 0.45-pm 
filter, and  frozen at  -20°C until tested.  Newly made IgG, present  in supernates of B-cell 
cultures, was determined by a sandwich radioimmunoassay  as described previously (7). Briefly, 
0.1  ml  of supernates was  incubated with  20 pg of human IgG and rabbit  human IgG at 
equivalence at 37°C for  1 h and at 4°C overnight. The precipitates were washed three times 
with ice-cold PBS containing I% human serum albumin and 0.5% Tween 20 (Atlas Chemical 
Industries, Inc., Wilmington,  Del.). The final precipitates were dissolved in 0.5 ml of 0.5% acetic 
acid, transferred to scintillation vials containing 10 ml of Instagel counting solution (Packard 
Instrument  Co., Inc., Downers Grove, I11.) and counted in a Packard Tri Carb liquid scintillation 
counter (Packard Instrument Co., Inc.). IgG with anti-TT antibody activity was determined as 
125  follows. To 0.1  ml of B-cell supernates, 30,000 cpm (~10 ng) of  I-TT was added. After an 
initial 1-h incubation at 37°C, equivalent amounts of humfi.n IgG myeloma (devoid of anti-TT 
activity) and of rabbit anti-human IgG (preabsorbed with 'IT cross-linked to Sepharose 4B) 
were added. The precipitates were washed as described above and counted in a Packard gamma 
scintillation counter (Packard Instrument Co., Inc.). The amount of radioactivity precipitated 
was compared  to  the  radioactivity precipitated with  different dilutions of a  standard IgG 
preparation of known anti-TT antibody content. 125I-DT and rabbit anti-human IgG preab- 
sorbed with DT cross-linked to Sepharose 4B were used in control experiments. Specificity of 
these  radioimmunoassays was  established  by  demonstrating that  cold  unlabeled  antigen 
completely inhibited the precipitation of radiolabeled antigen. 
Absorption of T-Cell  Supernates with  Antisera Cross-Linked to  Sepharose 4B.  2-ml  aliquots of 
unfractionated  LMF-TT, NSF, or ASF were  incubated with 0.5  ml of Sepharose 4B  beads 
cross-lined, respectively, to the IgG fraction of antisera directed against human IgG, IgM, and 
B-cell alloantigens (Ia analogues). The incubation was carried in 12  ×  75 mm Falcon plastic 
tubes for 6 h at 4°C with continuous  rotation. The beads were then sedimented by centrifugation 
(5 min, 200 g), and the supernatant material was collected, millipore-fihered, and assayed on 
B cells. 
Effect of Anti-DRW Antisera on B-Cell Cultures.  Anti-DRW antisera were heat inactivated at 
56°C for 45 rain and added at a final dilution of 1:10 to B-cell cultures. 
Treatment with Enzymes.  2-ml aliquots of ASF were incubated  with the following insolubilized 
enzymes:  10 U  trypsin, 5 U  ficin, 20 nag amylase,  1,000 U  DNAase, and 5 U  RNAase. The 
incubation was carried at  room  temperature for  6  h,  at  the end of which  the cross-linked 
enzymes were pelleted by centrifugation (5  min, 200 g)  and the supernatant material was 
collected, millipore-filtered, and assayed on B cells. 1036  ANTIGEN-SPECIFIC  ItELPER  FACTOR IN  MAN 
TABLE  I 
Effect of LMF-TT, NSF, and ASF on Autologous B 
Cell Cultures 
MI total lgG synthesis  IgG anti-TT synthe- 
ttelper factors  A(P-R) cpm t4C-IgG*  sis A(P-R) tz~I  cpm:~ 
I,MF-TT  10.5  +9,120  +3,250 
NSF +  TT  8.2  +8,830  +2,764 
ASF  1.1  -92  + 21 
ASF +  TT  1.0  + 130  +2,843 
'~ cpm of 14C-IgG  secreted by I x  I0" B cells. 
:~ cpm of 12'~I-TT precipitated by the supernates of 1 X  I(Y  i B cells. 
Sephadex CLIO0 Gel Chromatography.  A  1.5  X  100-cm  Sephadex G-100 column  (Pharmacia 
Fine Chemicals,  Div.  of Pharmacia  Inc.)  maintained at  4°C  was  calibrated with  different 
protein markers obtained from Schwarz/Mann Div. Becton, Dickinson, & Co., Orangeburg, N. 
Y.: Rabbit IgG (mol wt  150,000),  bovine serum albumin (tool wt 68,000), ovalbumin (mol wt 
43,000), chymotrypsinogen A  (tool wt 25,000),  myoglobin (mol wt  17,800)  and cytochrome c 
(mol wt  12,500).  10 ml of material of freshly isolated ASF were loaded into the column. The 
column was washed using PBS at a flow rate of 18 ml/min and  10-ml fractions were collected. 
Fractions were pooled according to desired molecular weight  ranges determined by previous 
calibration then, concentrated to original volume by using an Amicon PMI0 (Amicon Corp., 
Scientific Sys.  Div.,  Lexington,  Mass.),  millipore-filtered (0.45-/~m filter), and  tested  on  B 
lymphocytes in the presence of 2 ~g/ml qT. 
Results 
Effect  of LMF-TT,  NSF,  and ASF on  B  Cells.  LMF-TT  and  NSF  eluted  sponta- 
neously after passage of LMF-TT  over a  TT immunosorbent column caused vigorous 
proliferation, IgG synthesis, and  IgG anti-TT synthesis in autologous B  cells (Table 
I and II). The addition of DT antigen to B-cell cultures containing LMF-TT  or NSF 
resulted in anti-DT antibody synthesis (Table I). 
ASF isolated over a ~  immunosorbent column caused no significant proliferation 
or IgG synthesis in autologous B  cells (Table I). However,  in the presence of added 
TT, ASF induced anti-TT antibody synthesis in autologous B  cells (Table I  and II). 
Addition of DT antigen  to ASF did not result in anti-DT antibody synthesis by the 
B-cell cultures. When LMF-TT  was fractionated over a  DT immunosorbent column, 
the 3 M  NaCNS eluate from that column did not induce antibody synthesis in B cells 
regardless of whether DT or TT were present in the B-cell cultures (Table II). 
ASF isolated over an anti-TT immunosorbent column showed properties similar to 
those of ASF isolated over a  TT  immunosorbent  column  (Table II). However, ASF 
isolated in this manner did not require the addition of TT to express its activity on B- 
cell cultures because the 3 M  NaCNS eluate from the anti-TT immunosorbent column 
contained  most of the TT  antigen originally present in the T-cell supernates. When 
LMF-TT  was  passed  over  an  anti-DT column,  the  3  M  NaCNS  eluate  from  that 
column  failed to  induce specific antibody synthesis in  autologous  B  ceils (data not 
shown). 
Effect of Anti-DRW Antisera  to Ia-Like Antigens  on ASF Actwity.  Adsorption of ASF 
over  immunosorbent  columns  containing  antisera  to  DRW  antigens  of the  donor 
whose cells were used as a  source of ASF, resulted in significant loss of ASF activity 
in eight of nine experiments using the B cells from six different donors. The exception 
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TABLE II 
Effect of Antigen and Antibody Immunosorbent Columns on the Activity of LMF-TT on Autologous B-cell 
Cultures 
Passage over immunosor-  Eluate assayed  Antigen present in 
bent  B-cell culture 
IgG synthesis* 
Anti-TT  Anti-DT 
A(P-R) cpm 1~5I 
Sepharose  Spontaneous  "IT  + 5,387  + 127 
Spontaneous  TT, DT  + 5,063  + 1,036 
Sepharose-TT  Spontaneous  TT  + 6,687  + 64 
Spontaneous  TT, DT  + 5,750  + 963 
3 M NaCNS  None  +312  + 177 
3 M NaCNS  TT  + 7,625  -109 
3 M NaCNS  DT  +421  +82 
SepharoseDT  Spontaneous  TT  + 5,512  -53 
3 M NaCNS  None  - 71  + 20 
3 M NaCNS  TT, DT  +46  +117 
Sepharose anti-TT  Spontaneous  TT  + 4,781  + 216 
3 M NaCNS  TT, DT  +3,810  +39 
* Results are expressed as cpm of 125I-radiolabeled antigen precipitated by the supernatant fluid of 1 ×  l0  s 
B cells. 
DRW  5,6 antiserum  to affect  the  activity of ASF derived  from a  DRW  4,  DRW  5 
donor  (Table  III). The loss of ASF activity that  occurred after  absorption  with  the 
relevant anti-DRW antisera ranged from 34 to 71% in eight experiments. Absorption 
of ASF with insolubilized  antisera  that  did  not  recognize the DRW  antigens  of the 
ASF  donor  resulted  in  no  significant  loss  of ASF  activity  (<1 1%)  in  five  of five 
experiments using the cells of five different donors (Table III). 
In eight of nine experiments using the B cells from six different donors, ASF activity 
was  inhibited  by  the  addition  of antisera  recognizing  B-lymphocyte  antigens  on 
cultured  B  cells  (Table III). The exception  is again  represented  in Table III by the 
failure of the anti-DRW 5,6 antiserum  to affect the response of B cells from DRW 4, 
DRW  5 donor to autologous ASF. In five of five experiments,  the response of ASF of 
B  cells  from  five  different  donors  was  not  affected  by  the  presence  of anti-DRW 
antisera which did not recognize the DRW antigens present  on the cultured  B cells. 
The activity of unfractionated LMF-TT and NSF was not inhibited  by antisera to 
B-lymphocyte antigens and was not absorbed by such antisera regardless of whether 
the antisera recognized antigens present on the B cells of the ASF donor or not (data 
not shown). 
Adsorption  of ASF on  Anti-IgM and Anti-IgG  Immunosorbents.  Passage  of ASF  over 
immunosorbent  columns  containing  rabbit  antisera  specific  to  the  heavy  chain 
determinants  of human  IgG and  IgM did  not  result  in  loss of ASF activity  (Table 
IV). 
Adsorption  of ASF on  Immunosorbents  Containing  Anti-Idiotypic  Antiserum.  Passage  of 
ASF over immunosorbent columns containing the Ig fraction of an idiotypic antiserum 
to F  (ab)2 anti-TT derived from the ASF donor resulted in an almost complete loss of 
ASF activity  (Table  IV).  Passage of ASF over immunosorbent  columns containing 
normal  rabbit  IgG or the IgG fraction of an idiotypic antiserum  to F (a6)2 anti-TT 1038  ANTIGEN-SPECIFIC  HELPER  FACTOR  IN  MAN 
TABL~  III 
Effect of Antisera to B-Cell Alloantigens  on ASF Activity* 
B-cell alloantigen  Passage over immuno-  Alloantisera present in 
of donor  sorbent  B-cell cultures 
Anti-TT 
synthesis:t:  Percent 
~t(P-R)  inhibition 
cpm x~I 
DRW3  +  DRW5 
Anti-DRW  4,5,6 
Anti-DRW  5,6 
Anti-DRW  6,7 
--  5,080  -- 
--  2,489  52 
--  1,619  68 
--  4,635  9 
Anti-DRW  4,5,6  2,269  58 
Anti-DRW  5,6  2,030  60 
Anti-DRW  6,7  4,466  14 
DRW4  +  DRW5  --  --  3,515  -- 
Anti-DRW  4,5  --  2,163  39 
Anti-DRW  5,6  --  3,415  2 
--  Anti-DRW  4,5  1,840  48 
--  Anti-DRW  5,6  2,978  15 
DRW4  +  DRW7  --  --  5,233  -- 
Anti-DRW  4,5  --  3,216  38 
Anti-DRW  5,6  --  5,l 10  2 
--  Anti-DRW  4,5  2,964  43 
--  Anti-DRW  5,6  4,837  8 
DRW3  +  DRW7  --  --  4,612  -- 
Anti-DRW  6,7  --  2,108  54 
Anti-DRW  4,5  --  4,465  3 
--  Anti-DRW  6,7  1,882  59 
--  Anti-DRW  4,5  4,071  12 
* ASF was assayed on autologous B cells. 
~: counts per minute a25I-TT precipitated by the supernate of 1  ×  l0  s B cells. 
from a donor different than the ASF donor did not result in loss of ASF activity. 
Susceptibility of ASF to Enzymes.  The proteolytic  enzymes  ficin  and  trypsin  com- 
pletely destroyed ASF activity. ASF was resistant to treatment with DNAase, RNAase, 
and amylase (Table V). 
Gel Filtration of ASF on Sephadex G-100.  After gel filtration over Sephadex G-100, 
ASF activity was recovered in fractions where proteins of mol wt of 25,000-75,000 are 
eluted  (Table VI). 
Discussion 
The data  presented  in  this  paper demonstrate  that  supernates  of TT-stimulated 
human T  cells contain, in addition  to the previously described NSF, an ASF capable 
of inducing anti-TT antibody synthesis in autologous B lymphocytes. The presence of 
both NSF  and  ASF  together  in  supernates  of antigen-stimulated  human  T  cells  is 
similar to the findin~ of Marrack and Kappler (15) in the murine system. ASF differs 
in several respects from NSF.  NSF behaves like a  polyclonal B-cell activator in that 
it triggers as much as 50% of autologous as well as allogeneic cells into proliferation 
and IgG synthesis and can induce specific antibody synthesis to a variety of antigens F.  B.  MUDAWWAR,  E. J.  YUNIS,  AND  R.  S.  GEHA 
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Absorption of ASF over Immunosorbent Columns Containing Anti-# Chain, Anti- 7 Chain, 




Experiment  Passage over immunosorbent  synthesis* A(p.  hibition 
R) 12Sl cpm 
1  None  + 7,099  -- 
Anti-IgG  + 5,800  18 
Anti-IgM  + 7,254  -2 
Anti-HSA  + 6,914  3 
None  + 5,050  -- 
Rabbit IgG  + 4,083  19 
Rabbit anti-idiotypic 
IgG directed against$ 
F (ab)2 anti-TT of ASF donor  +579  89 
Rabbit anti-idiotypic 
IgG directed against§ 
F (ab)2 anti-TT of unrelated donor  + 3,865  23 
* cpm of 12nI-'I'T precipitated by the supernatant fluid of 1 ×  10  n B cells. 
:l: The IgG from this antiserum at a  concentration of 10 mg/ml had a  binding capacity of 
950 ng of immunizing F  (ab)2 anti-TT per milliliter as calculated from the 50% binding 
point ofa radioimmunoassay utilizing 20 ng of radiolabeled F (ab)2 anti-TT and decreasing 
amounts of antiserum starting with 100/xl. Precipitates were made by using normal rabbit 
IgG and goat anti-rabbit IgG at equivalence. 100 ml of this anti-idiotypic IgG inhibited by 
more than 95% the binding of radiolabeled TT to 2 #g of IgG derived from the donor of 
the immunizing F  (ab)2 anti-TT.  This assay was carried by adding different amounts of 
anti-idiotypic IgG  to  2  #g of human  IgG  and  10  ng of radiolabeled "IT.  These latter 
amounts were chosen because they resulted in binding of 70% of the labeled TT to the 
human IgG which was precipitated using a  myeloma IgG and rabbit anti-human IgG at 
equivalence. Anti-idiotypic IgG was coupled to an equal volume of packed Sepharose 4 B 
beads. 
§ The IgG from this antiserum at a  10-mg/ml concentration had binding capacity of 1,330 
ng of immunizing F (ab)2 anti-'IT per milliliter. 100 nl of this antiserum inhibited by 90% 
the binding of radiolabeled TT to IgG derived from the donor of the immunizing F  (aB)z 
anti-TT.  1130 nl of this anti-idiotypic IgG completely failed to bind to any of 20 ng of X~l- 
radiolabeled (FaB)2 anti-TT derived from the ASF donor and completely failed to inhibit 
the binding of radiolabeled TT to IgG derived from the ASF donor. All assays and the 
binding to Sepharose 4B were done as described in preceding paragraph. 
TABLE  V 
Effect of Enzyme Treatment on ASF Activity 
Anti-anti-TT* 
Treatment  A(P-R)cpm 1251  Percent inhibition 
None  7,566  -- 
DNase  9,074  19 
RNase  6,004  21 
Amylase  5,480  28 
Ficin  470  94 
Trypsin  531  93 
* cpm of 1251-TT precipitated by the supernatant fluid of 1 ×  106 B cells. 1040  ANTIGEN-SPECIFIC  HELPER  FACTOR IN MAN 
TABLE VI 
Estimate of Molecular Weight of ASF by Gel Filtration on Sephadex G-IO0 
lgG anti-TT synthesis* 
A(P-R) cpm 1251 
7,099  Unfractionated  ASF 
Sephadex G- 100 eluants§ 
Fraction I  68 
Fraction II  5,711 
Fraction III  5,794 
Fraction IV  619 
Fraction V  178 
* cpm of 125I-Tr precipitated by the supernatant fluid of 1 ×  108 B cells. 
The range  of the  molecular  weights is: fraction  I, >75,000; fraction  II, 
50,000-75,000; fraction III, 25,000-50,000; fraction IV, 12,500-25,000; frac- 
tion V, <12,500. The column was calibrated with human gammaglobulin 
(150,000), bovine serum albumin (68,000), ovalbumin  (43,000), bovine pan- 
creas ehymotrypsinogen A (25,000), and horse heart cytochrome c (12,500). 
All fractions were concentrated  to a volume equal to the original volume of 
ASF applied to the column. 
added to the B-cell culture  (7). Whereas, ASF triggers B  cells into specific antibody 
synthesis, it can induce antibody synthesis only in the presence of the antigen used to 
stimulate helper factor production T  cells (Tables I  and II). 
ASF was  isolated from  unfractionated  T-cell supernates  by  adsorption onto  im- 
munosorbent  columns containing cross-linked TI" antigen. The  material that  spon- 
taneously  eluted  from  such  columns  was  previously  shown  to  contain  NSF.  The 
material that  bound to the column and was eluted with 3  M  NaCNS demonstrated 
ASF activity. ASF exhibited affinity exclusively to the TI" antigen, which was used to 
stimulate helper factor production, but not to unrelated antigens such as DT. It seems 
that the affinity of ASF to cross-linked antigen is significantly higher than its affinity 
to soluble antigen because soluble TT  antigen was present in the unfractionated T- 
cell supernates  (LMF-TT). Furthermore, because soluble TT  was shown  not to stick 
nonspecifically to the column,  as demonstrated using trace amounts of radiolabeled 
TT, it is unlikely that complexes of ASF and soluble TT  (or "IT fragments) absorbed 
nonspecifically to  the  column.  Therefore,  ASF  must  have  preferentially bound  to 
insolubilized TT  in the presence of soluble TT  antigen. This higher affinity of ASF 
to  insolubilized antigen  is in  full agreement  with  the data of Munro  et  al.  (16)  on 
murine ASF induced by the synthetic antigen (T, G)-A--L. 
ASF could  also be  isolated from  supernates  of TT-stimulated  human  T  cells by 
passage over an  immunosorbent  column  containing  rabbit  anti-TT  antibody.  It  is 
likely  that  under  these  conditions  soluble  TT  contained  in  the  T-cell  supernates 
bound to the insolubilized rabbit anti-TT and the resulting immobilized TT antigen 
retained ASF. Again, this retention was antigen specific in that ASF activity was not 
retained on immunosorbent columns containing antibody to DT. 
ASF activity was expressed only in the presence of the antigen TT that was used to 
generate ASF. Thus,  the material that bound to insolubilized TT caused autologous 
B  cells  to  synthesize  specific  anti-TT  antibody  only  if  TT  antigen  was  added 
concomitantly to the B-cell cultures. Addition of an unrelated antigen such as DT to 
these cultures  in  the presence of ASF did not  result  in  anti-DT antibody synthesis, F. B. MUDAWWAR, E. J.  YUNIS, AND R. S. GEHA  1041 
demonstrating that ASF activity is exquisitely antigen specific. The antigen specificity 
of human ASF is in full agreement with the data on murine ASF (5,  15,  16). 
ASF  caused  negligible  proliferation  and  IgG  production  in  B  cells.  This  is  in 
contrast to the NSF, previously shown to be present in the same unfractionated T-cell 
supernates,  and  which  induced  proliferation  in  as  much  as  50%  of the  B  cells 
accompanied by vigorous IgG synthesis, only a small fraction of which had specificity 
to the TT antigen (7). It is probable that ASF triggers only those B cells that recognize 
TT antigen and that TT antigen may serve to focus ASF on the TT-specific B cells 
by binding to TT-specific surface immunoglobulin receptors. Because TT-specific B 
cells constitute a small fraction of the total number of B cells, triggering of the TT- 
binding B cells by ASF is therefore not expected to result in detectable proliferation 
or vigorous IgG synthesis. 
The antigen-binding  moiety in  ASF  is not  a  classical  immunoglobulin  molecule 
because ASF was  not  retained on columns containing antisera to the heavy chain 
determinants  of human  IgG  and  IgM.  However,  ASF  was  retained  on  columns 
containing anti-idiotypic antiserum raised in rabbits against F  (al~)2 anti-TT derived 
from the ASF donor. ASF activity was  not  diminished  after passage over columns 
containing anti-idiotypic antiserum raised against F (al~)2 anti-TT from an unrelated 
donor shown not to possess cross-reactive idiotypic determinants with the ASF donor. 
This  data  suggests  that  ASF  shares  antigen-binding  idiotypic  determinants  with 
circulating antibody molecules. Because the T  cell is the source of ASF and because 
shared antigen-binding idiotypic determinants has been identified on the surface of 
both B and T  cells in experimental animals (17) it is likely that ASF contains the T- 
cell receptor for antigen.  This data  is  in  agreement  with  recent  data obtained by 
Mozes  (18)  demonstrating  that  murine  ASF  binds  to  insolubilized  anti-idiotypic 
antibodies. 
With one exception, insolubilized anti-DRW antisera (antisera to Ia analogues) of 
the ASF donor partially removed ASF activity, suggesting that ASF contains Ia-like 
B-lymphocyte alloantigens. The exception represents the failure of an antiserum that 
recognizes  DRW  5  and  DRW  6  antigens  to  absorb  ASF  derived  from  a  donor 
possessing the DRW 4 and DRW 5 antigens  (Table III). Also, when this antiserum 
was added to cultures of B cells from the same donor, it failed to inhibit the B-cell 
response to autologous ASF. This failure cannot be explained by the antiserum being 
a weak one because the same antiserum absorbed substantially ASF derived from a 
second donor possessing the DRW 3 and DRW 5 antigens (Table III). It is possible, 
however, that much greater quantities of ASF were present in the T-cell supernates 
of the first donor exceeding the absorption capacity of the anti-DRW 5,6 antiserum. 
A more attractive, but equally speculative, possibility is that  the antigenic determi- 
nants present  in ASF may not be DRW antigens but the product of a  gene closely 
linked to DRW 5 and absent in the donor possessing the DRW 4, DRW 5 antigens 
whose ASF activity was not affected by absorption with the anti-DRW 5,6 antiserum. 
Similarly,  and  with  the  same  exception  discussed  above,  anti-DRW  antisera 
inhibited  the  B-cell  response  to  ASF  when  they were added  to  the  B-cell culture 
provided they recognized DRW antigens present on the B cells. In contrast, the B-cell 
response  to  NSF  was  not  inhibited  by  the  addition  of anti-DRW  antisera  that 
recognized the B-cell DRW antigens indicating that these antisera were not irrevers- 
ibly inactivating, or killing, B cells under the present culture conditions. 1042  ANTIGEN-SPECIFIC  HELPER  FACTOR IN MAN 
In all experiments, anti-DRW  antisera that did not  recognize DRW  antigens on 
the  ASF  donor  failed  to  either  absorb  ASF  or  interfere  in  culture  with  the  B-cell 
response to ASF. 
Because  ASF  is  the  product  of antigen-activated  T  cells,  the  source  of Ia-like 
antigens in ASF may be the activated T  cell itself, which has been demonstrated by 
David  et  al.  (19)  to  express  Ia  antigens,  or  the  Ia-bearing  macrophage  which  is 
necessary for the T-cell activation by antigen. The present experiments do not allow 
a distinction between these two possibilities. 
Whereas it has been clearly demonstrated in mice that the Ir-region determinants 
present on ASF are coded for the I-A subregion, no such analysis is at present feasible 
in  man.  Tissue  typing  for  human  B-lymphocyte antigens  is  still  far  from  being 
exhaustive and the human alloantisera available are not sufficiently monospecific and 
do not distinguish between the putative determinants coded for by subregions of an 
Ir-like region of the human major histocompatibility complex. The observation that 
ASF from a single donor was inhibited by one but not the other of two antisera that 
recognized the DRW 5 antigen on the B cells of that donor suggests that the antigenic 
determinants present  in ASF may not be DRW 5 but  the product of a  gene closely 
linked  to DRW 5  and  recognized by only one of the two antisera tested.  Evidence 
that human B-cell alloantigens are coded for by more than one locus has been recently 
presented by several groups (20-22).  Identification of which subregion of the Ir-like 
region in man is represented in ASF should be possible whenever antisera capable of 
distinguishing  the products of the human  Ir-like subregion  genes become available. 
Summary 
Supernates of tetanus toxoid  (TT) antigen-stimulated human T  cells were studied 
for the  presence of an  antigen-specific T-cell helper  factor  (ASF).  Supernates  were 
circulated  over an  immunosorbent  column  consisting  of insolubilized  TT  antigen. 
The material  which  bound  to  the  column  was eluted  with  3  M  NaCNS  and  was 
shown to contain a  factor which in the presence of TT-induced specific IgG anti-TT 
antibody synthesis in autologous B cells without causing readily detectable prolifera- 
tion.  ASF  activity  was  partially  inhibited  by  antisera  directed  against  the  B-cell 
alloantigens  of the  ASF  donor.  Immunosorbent  columns  containing  such  antisera 
removed ASF activity.  Immunosorbent columns containing  antisera  to human  im- 
munoglobulin  heavy  chain  determinants  did  not  remove  ASF  activity;  whereas 
immunosorbent columns containing rabbit idiotypic antiserum directed against anti- 
TT antibodies  completely removed ASF activity. ASF was destroyed  by treatment 
with proteolytic enzymes; its molecular weight was estimated by Sephadex G-100 gel 
column chromatography to be between 25,000 and 75,000 daltons. 
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